Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Health

Russia's RDIF signs deal to produce Sputnik V vaccine in China

FILE PHOTO: Bottles of Russia's "Sputnik-V" COVID-19 vaccine are seen before inoculation at a clinic in Tver, Russia, October 12, 2020. REUTERS/Tatyana Makeyeva

Russia's RDIF sovereign wealth fund and China's Shenzhen Yuanxing Gene-tech have agreed to produce over 60 million doses of Russia's Sputnik V vaccine against COVID-19 in China, RDIF said on Monday.

RDIF, which is marketing Sputnik V globally, said that commercial production was due to start in May.

(Reporting by Maria Kiselyova; writing by Tom Balmforth; editing by Louise Heavens)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.